Previous 10 | Next 10 |
home / stock / cvalf / cvalf news
Covalon Technologies Ltd. (CVALF) Q1 2023 Results Conference Call February 23, 2023 09:00 AM ET Company Participants Brian Pedlar - President and Chief Executive Officer Jason Gorel - Interim Chief Financial Officer Presentation Operator Good morning, l...
Covalon Technologies press release ( OTCQX:CVALF ): Q1 GAAP EPS of -$0.02. Revenue of $6.2M (+26.5% Y/Y). Licensing and royalty fees for the three months ended December 31, 2022 were $0.1 million, compared to $0.05 million for the three months ended December 31, 2021. Ad...
Covalon Announces Improved First Quarter Fiscal 2023 Results Canada NewsWire Revenue growth of 25%, significant margin improvement and strong balance sheet MISSISSAUGA, ON , Feb. 23, 2023 /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSX...
Infection Prevention Solutions Provider Covalon to Participate for the First Time in NEO - The Conference for Neonatology in Las Vegas, NV on February 22-24, 2023 Canada NewsWire Visit booth 100 to learn how Covalon's products are uniquely designed to help prevent CLABSIs and ...
Covalon Announces Conference Call to Discuss First Quarter Fiscal 2023 Financial Results Canada NewsWire MISSISSAUGA, ON , Feb. 17, 2023 /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies co...
The following slide deck was published by Covalon Technologies Ltd. in conjunction with their 2023 Q4 earnings call. For further details see: Covalon Technologies Ltd. 2023 Q4 - Results - Earnings Call Presentation
Covalon Technologies press release ( OTCQX:CVALF ): Q4 GAAP EPS of -$0.16. Revenue of $5.39M (-10.6% Y/Y). Adjusted gross margin of 49%. For further details see: Covalon Technologies GAAP EPS of -$0.16, revenue of $5.39M
Covalon Announces Fourth Quarter and Year End Results for Fiscal 2022 and Highlights Company Transformation Changes Canada NewsWire MISSISSAUGA, ON , Jan. 25, 2023 /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advan...
Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2022 Financial Results Canada NewsWire MISSISSAUGA, ON , Jan. 23, 2023 /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical t...
MISSISSAUGA, ON / ACCESSWIRE / November 29, 2022 / Covalon Technologies Ltd. (TSXV:COV; OTCQX:CVALF), an advanced medical technologies company, today announced that it will be presenting at the Planet MicroCap Investor Showcase: VIRTUAL 2022 on Wednesday, December 7, 2022 at 8:30 AM EST. Bri...
News, Short Squeeze, Breakout and More Instantly...
Recent changes and effective execution pave the way for strong Q2 results Q2 EBITDA of $1.7 million, Adjusted EBITDA of $2.5 million, and EPS of $0.06 Q2 year-on-year Revenue growth of 16%, focus area of US Product segment grew 54% Q2 Gross Margin increased to 63%, the h...
Faraday Future Intelligent Electric Inc. (FFIE) is expected to report for Q1 2024 D-Market Electronic Services & Trading (HEPS) is expected to report for Q1 2024 Christian Dior SE ADR (CHDRY) is expected to report for Q1 2024 Check-Cap Ltd. (CHEK) is expected to report $-0.17 for ...
Covalon Technologies Ltd. (CVALF) is expected to report for Q2 2024